Storia in 2 fonti

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

Raccontata da

benzinga.com

morningstar.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo13 h fa

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

originale

benzinga.com13 h fa

EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO - Immunic (NASDAQ:IMUX)

Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis drug launch experience accelerates Immunic's Phase 3 trials in…

Leggi questa versione → originale

Timeline cronologica

mercoledì 27 maggio 2026·benzinga.com
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO - Immunic (NASDAQ:IMUX)
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis drug launch experience…
mercoledì 27 maggio 2026·morningstar.com
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer